As for healthy donors, the global frequency of MELOE-1 specific CD4 T cells can be roughly estimated and ranged from 2.5×10−7 to up to 6.5×10−6 among CD4 T cells from melanoma patients. The gene discussed is CD4; the disease is melanoma.